Hosted on MSN3mon
MeMed’s sepsis test receives FDA breakthrough device statusMeMed has received breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its MeMed Severity test, designed to enhance the management of patients with suspected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback